SCHEMBL908706

SCHEMBL908706

COc1nc(Cl)ccc1NC=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MERTK Q12866 1/20 0.37
MAPT P10636 3/20 0.36
MAPK1 P28482 1/20 0.36
ALDH1A1 P00352 3/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
OR51E2 Q9H255 1/20 0.35
LMNA P02545 2/20 0.35
CCR4 P51679 5/20 0.35
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
HTT P42858 1/20 0.34
TDP2 O95551 1/20 0.33
NSD2 O96028 1/20 0.33
LRRK2 Q5S007 1/20 0.32
TUBB4A P04350 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22149661 0.82 PDE4D (0.36) MAPTMAPK1ALDH1A1GAACRHBP
SCHEMBL11993104 0.82 MAPT (0.37) MAPTGAALMNACRHBPCRHR2
SCHEMBL11993108 0.80 MAPK1 (0.35) MAPTMAPK1ALDH1A1GAASMN1; SMN2
SCHEMBL154070 0.79 CCR4 (0.35) MAPTMAPK1ALDH1A1OR51E2CCR4
SCHEMBL19002845 0.78 CRHBP (0.38) MERTKMAPTMAPK1ALDH1A1GAA
SCHEMBL11993093 0.76 KDM5A (0.34) ALDH1A1
SCHEMBL15508168 0.76 TTK (0.42) MAPTMAPK1HPGDSMN1; SMN2OR51E2
SCHEMBL11993092 0.75 HDAC3 (0.34) SMN1; SMN2L3MBTL1
SCHEMBL18979088 0.75 ALDH1A1 (0.48) MAPTMAPK1ALDH1A1HPGDSMN1; SMN2
SCHEMBL3707609 0.75 MAPT (0.47) MERTKMAPTMAPK1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9453000-B2 Polycyclic compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2016-09-27 US disclosed
EP-2181992-B1 POLYCYCLIC COMPOUND EISAI R&D MAN CO LTD (JP) 2013-05-01 EP disclosed
EP-2559693-A1 Polycyclic compound Eisai R&D Management Co., Ltd. (JP) 2013-02-20 EP disclosed
US-7935815-B2 Imidazoyl pyridine compounds and salts thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-05-03 US disclosed
US-20110065696-A1 IMIDAZOYL PYRIDINE COMPOUNDS AND SALTS THEREOF KIMURA TEIJI 2011-03-17 US disclosed
US-20110009619-A1 POLYCYCLIC COMPOUND EISAI R&D MANAGEMENT CO., LTD. (JP) 2011-01-13 US disclosed
EP-2181992-A1 POLYCYCLIC COMPOUND Eisai R&D Management Co., Ltd. (JP) 2010-05-05 EP disclosed
US-20090062529-A1 MULTI-CYCLIC COMPOUNDS EISAI R&D MANAGEMENT CO., LTD., (JP) 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009619-A1 POLYCYCLIC COMPOUND APP, BACE1, PSEN1 MERTK 3945/4885MAPT 31/4885MAPK1 240/4885
US-20110065696-A1 IMIDAZOYL PYRIDINE COMPOUNDS AND SALTS THEREOF APP, PSEN1, BACE1 MERTK 1983/4885MAPT 20/4885MAPK1 62/4885
US-20090062529-A1 MULTI-CYCLIC COMPOUNDS APP, BACE1, PSEN1 MERTK 2646/4885MAPT 31/4885MAPK1 297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.